Weight change after an atypical antipsychotic switch

Annals of Pharmacotherapy

Volumn 37, Issue 10, 2003, Pages 1381-1386

  Ried, L Douglas ^a,b,d   Renner, Bernard T ^a   Bengtson, Michael A ^b,c   Wilcox, Brian M ^b   Acholonu Jr , Wilfred W ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Atypical antipsychotics; Olanzapine; Risperidone; Weight gain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BODY WEIGHT; COMORBIDITY; CORONARY ARTERY DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT GAIN;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; BODY WEIGHT; HUMANS; MIDDLE AGED; OBESITY; PILOT PROJECTS; RETROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA;

EID: 0141781280     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C470     Document Type: Article

References (22)

1. Rice RP. The economic impact of schizophrenia. J Clin Psychiatry 1999;60(suppl 1):4-6.
2. Buckley PF. Broad therapeutic uses of atypical antipsychotic medications. Biol Psychiatry 2001;50:912-24.
3. Masand PS, Berry SL. Switching antipsychotic therapies. Ann Pharmacother 2000;34:200-7 [erratum 2000;34:541]. DOI 10.1345/aph. 18458
4. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 2002;47:27-38.
5. Meyer JM. Effects of atypical antipsychotics on weight and serum lipid levels. J Clin Psychiatry 2001;62(suppl 27):27-34.
6. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96.
7. McIntyre RS, Mancini DA, Basile VS. Mechanisms of antipsychotic-induced weight gain. J Clin Psychiatry 2001;62(suppl 23):23-9.
8. Aronne LJ. Epidemiology, morbidity, and treatment of overweight and obesity. J Clin Psychiatry 2001;62(suppl 23):13-22.
9. Sussman N. Review of atypical antipsychotics and weight gain. J Clin Psychiatry 2001;62(suppl 23):5-12.
10. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001;46:273-81.
11. Allison DB, Fontaine DR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215-20.
12. Kingsbury SJ, Fayek M, Trufasiu D, Zada J, Simpson GM. The apparent effects of ziprasidone on plasma lipids and glucose. J Clin Psychiatry 2001;62:347-9.
13. Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6.
14. SPSS for Windows Release 10.0.5 (27 November 1999), Standard Version. Chicago, IL: SPSS.
15. Sachs GS, Guille C. Weight gain associated with use of psychotropic medications. J Clin Psychiatry 1999;60(suppl 21):16-9.
16. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age and the association between body mass index and mortality. N Engl J Med 1998;338:1-7.
17. Harvard Mental Health Letter. Antipsychotic drugs: the weight problem 2000. Harvard Health Online. www.health.harvard.edu/medline/Mental/M.1200e.html (accessed 3 Mar 2002).
18. American Heart Association. 2002 Heart and stroke statistical update 2002. www.americanheart.org (accessed 10 Jun 2002).
19. Boutelle KN, Kirschenbaum DS. Further support for consistent self-monitoring as a vital component of successful weight control. Obesity Res. 1998;6:219-24.
20. Wardle J, Griffith J. Socioeconomic status and weight control practices in British adults. J Epidemiol Commun Health 2001;55:185-90.
21. Kurzthaler I, Fleischhacker WW. The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 2001;62(suppl 7):32-7.
22. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997;66(suppl): 1044S-50S.